Tag: Alere
Arriva settles False Claims allegations for $160M
August 3, 2021HME News Staff
NASHVILLE, Tenn. – Arriva Medical and its parent company, Alere, have agreed to pay $160 million to settle allegations they violated the False Claims Act.
The federal government alleged that, from April 2010 until the end of 2016, Arriva, with Alere’s approval, paid kickbacks to Medicare beneficiaries by providing them free or no-cost glucometers and by routinely waiving, or not collecting, co-payments for meters and diabetes testing supplies. Specifically, it alleged that Arriva...
US joins lawsuit against defunct Arriva Medical
February 21, 2019HME News Staff
NASHVILLE, Tenn. - The U.S. Justice Department has joined in a lawsuit that alleges Arriva Medical offered Medicare beneficiaries “free upgrades” of glucometers.The lawsuit, filed under the False Claims Act, also alleges that Arriva and its parent company, Alere, submitted false claims for medically unnecessary glucometers, and paid kickbacks to beneficiaries in the form of free glucometers and co-pay waivers.Additionally, it alleges Arriva made no meaningful effort to collect co-pays...
Mail-order market for diabetes on precipice of disaster
November 10, 2017Theresa Flaherty, Managing Editor
CORAL SPRINGS, Fla. - With Arriva Medical, the largest mail-order supplier of diabetes testing supplies, closing its doors at the end of the year, industry stakeholders predict chaos.
Arriva serviced 450,000 Medicare beneficiaries in 2016, according to the latest information in the HME Databank.
“This is a disaster,” said Tom Milam, an industry consultant. “I think CMS has to find a way to react to this, but there's no other firm out there that has the infrastructure or...
Arriva Medical in 'midst' of ALJ appeal
April 21, 2017Theresa Flaherty, Managing Editor
CORAL SPRINGS, Fla. - Arriva Medical, a provider of diabetes testing supplies, remains confident that it will get its Medicare billing status reinstated.
That may be a big reason why Abbott Laboratories last week finally agreed to buy Alere, Arriva Medical's parent company, after months of court battles.
“Arriva is continuing to support its patients while working through the process of resolving the revocation of the billing number,” a spokesperson for parent company Alere told...
Abbott Labs, Alere deal moves forward
April 18, 2017HME News Staff
ABBOTT PARK, Ill., and WALTHAM, Mass. - Abbott Laboratories has agreed to buy Alere, but at a lower price than it previously offered.
Under amended terms, Abbott will pay $51 per common share to acquire Alere, for a new expected equity value of approximately $5.3 billion, reduced from $5.8 billion, according to a press release.
Abbott first announced plans to buy Alere in February 2016. Later that year, however, Abbott filed a complaint in the Delaware Court of Chancery, asking a judge to terminate...
Arriva gets day in court
January 11, 2017HME News Staff
WALTHAM Mass. - CMS has agreed not to terminate Arriva Medical's mail-order contract while the provider appeals to have its license reinstated.
An administrative law judge has required both parties to have initial briefings finished by Jan. 18. A hearing is scheduled for Feb. 8 before the Federal District Judge, stated Alere, Arriva Medicals's parent company, in a press release. CMS revoked Arriva Medical's billing privileges in November for allegedly submitting 211 claims...
In brief: CMS releases nat'l health expenditures, OIG says two brands dominate mail-order market for diabetes supplies
December 9, 2016HME News Staff
WASHINGTON - Per-capita healthcare spending grew by 5% and overall healthcare spending grew by 5.8% in 2015, according to a recent study by the Office of the Actuary at CMS.
Those rates continue to be below the rates of most years prior to the passage of the Affordable Care Act.
“Even as millions of people gained coverage, per-enrollee spending growth in private health insurance and Medicare continue to be well below the average in the decade before passage of the Affordable Care Act,”...
Abbott wants to ditch Alere
December 8, 2016HME News Staff
WALTHAM, Mass. - Abbott Laboratories has sued Alere in an effort to terminate its buyout of the company, according to news reports. Chicago-based Abbott has filed a complaint in the Delaware Court of Chancery, asking a judge to terminate the deal on the grounds that Alere is no longer the company Abbott agreed to buy 10 months ago. Alere's problems include CMS revoking the billing privileges of its DME supply business, Arriva Medical, amid allegations that it submitted claims for 211 dead patients...
CMS revokes Arriva's billing privileges
November 22, 2016HME News Staff
CORAL SPRINGS, Fla. - Arriva Medical's contract for CMS's national mail-order program for diabetes supplies is in question.
CMS has revoked Arriva's billing privileges, alleging the provider submitted 211 claims for deceased patients between April 15, 2011, and April 25, 2016, according to a statement from parent company Alere.
“However, the CMS letter only identifies a sample of 47 such patients, upon which our review was based,” reads the statement. “The 211...